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Abstract
Introduction: Respiratory syncytial virus (RSV) infection is the most common cause of hospitalization in infants and small children. The aim was to 
present a 13-months old boy diagnosed with acute airway infection, acute otitis media (AOM) and hepatitis during the RSV-infection.
Material and methods: Serum catalytic activities of alkaline phosphatase (ALP), aspartate aminotranspherase (AST), alanine aminotranspherase 
(ALT), gamma glutamyl transpherase (GGT), lactate dehydrogenase (LD), and concentrations of bilirubin were monitored during hospitalization and 
at control examination.
Results: The child had clinical signs and symptoms of respiratory failure, AOM, and laboratory fi ndings of virus infection and liver disease. On admi-
ssion, catalytic activities of enzymes were markedly increased, especially the activity of ALP (10333 U/L, i.e. 24-fold increase in comparison with the 
upper reference limit). The highest increased in AST (339 U/L, 4.5-fold), ALT (475 U/L, 10.3-fold) and LD (545 U/L, 1.5-fold) were registered on the 
3rd day, and the highest increase in GGT (68 U/L, 3.1-fold) occurred on the 11th day. Seven weeks after discharge AST, ALT, GGT and LD decreased into 
reference range, and ALP remain mildly increased (478 U/L, 1.1 fold increase). RSV was confi rmed in nasal lavage fl uid.
Conclusion: Laboratory results in patient with RSV infection needs to be interpreted in the light of both, respiratory and extrapulmonary manife-
stations of the infection, respectively.
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Respiratory syncytial virus (RSV) infection is the 
most common cause of hospitalization for pneu-
monia and bronchiolitis in infants and small chil-
dren (1). Epidemiological study concerning Zagreb 
County have shown that RSV-caused bronchiolitis 
has been registered in 52.7% of children who were 
hospitalized due to acute respiratory infection (2). 
The study confi rmed biennial cycle of RSV out-
breaks (3).
Mainly, bronchiolitis occurs in infants and small 
children up to two years of age. Bronchiolitis is 
seasonal illness (in the winter months), as RSV is 
widespread in the community. It is characterized 
by fever, nasal discharge, dry wheezy cough (the 
later because of small airway obstruction) (1). In-
fants and small children who are born prematurely 
(≤ 37 weeks) and children with cardiac disease are 
more susceptible to severe disease and have high-
er rates of hospitalization (4).
Recently, extrapulmonary manifestations (central 
nervous system, cardiovascular system, endocrine 
system and liver) of RSV-infection are described (5).
The aim of this paper was to present a 13-months-
old male child with clinical signs and symptoms of 
airway infection and acute otitis media (AOM), and 
laboratory fi ndings of liver disease during RSV-in-
fection.
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Material and methods
Case history
We present a case of a 13-month old boy, born at 
full term by Caesarean section, admitted to daily 
hospital department for the management of acute 
respiratory infection. The disease started ten days 
ago with productive cough. Febrility appeared 
four days before admission. On examination, the 
child was febrile (38.9 oC, axilary), had an impres-
sion of acute, moderately ill child. Mucosal secre-
tion and nasal congestion were found by rhynos-
copy. Pharyngeal mucosa was moderately hypere-
mic. Respiration rate was 40 breaths per minute. 
Bronchial breath sounds over the large airways 
and light wheezing were registered. Normal re-
sults on a pulse oximetry were registered (i.e. lev-
els above 96% oxygenated haemoglobin). Signs 
and symptoms of pneumonia were not presented. 
Otoscopy has shown prominent and hyperemic 
right eardrum. Auscultatory, heart sounds were 
normal. Some angular lymph nodes were enlarged 
(diameter up to 5 mm), elastic and movable. Liver 
edge was palpable just below right costal margin. 
Finally, diagnoses of acute rhinopharingitis, acute 
rhinitis, obstructive bronchitis and right-side otitis 
media were confi rmed. Serial determination of 
haematological and biochemical parameters were 
performed during hospitalization.
The patient was treated with salbutamol inhala-
tions, decongestans and antipyretics. Salbutamol 
(0.15 mg/kg) was administered through nebulizer, 
according to the GINA guidelines (GINA, Global Ini-
tiative for Asthma) (7). Side eff ects of salbutamol 
therapy were not registered. In addition, respira-
tory physiotherapy and airway toilet were per-
formed. After 11 days, the patient was discharged 
with normal clinical status for home care. Control 
physical examination and laboratory testing were 
performed on day 49 of the admission to daily hos-
pital. The patient’s mother signed the informed 
consent form prior to admission to daily hospital. 
Diagnostic work-up was performed according to 
the standardized procedure, in line with ethical 
principles, Helsinki Declaration on Human Rights 
from 1975 and Seoul amendments from 2008.
Laboratory measurements
Determination of alkaline phosphatase (ALP), as-
partate aminotranspherase (AST), alanine ami-
notranspherase (ALT), gamma glutamyltrans phe-
rase (GGT), lactate dehydrogenase (LD), bilirubin, 
C-reactive protein (CRP) and iron in serum were 
performed on Beckman Coulter AU 400 analyzer 
with original commercial reagents (Beckman Coul-
ter, Munich, Germany) according to the recom-
mended/harmonized methods (6). Erithrocyte sedi-
mentation rate (ESR) was performed using the cen-
trifugal laboratory analyzer Vesmatic 20 (DIESSE Di-
agnostics, S. Martino, Italija). Sysmex 1800i automat-
ed hematology analyzer (Sysmex Corporation, 
Kobe, Japan) was used for the determination of leu-
kocyte count. Nasal wash kit has been used in the 
collection of nasal washing for RSV antigen isolation 
and detection (direct testing for RSV antigen).
Results
Dynamic changes of laboratory fi ndings occurred 
during serial monitoring (Table 1). At admission, 
catalytic activity of ALP was markedly elevated 
(10333 U/L, i.e. 24.3-fold elevation in comparison 
with the upper reference value of 425 U/L). There-
after, it decreased to 8640 U/L (at day 3; 84% of ini-
tial value), to 3080 U/L (at day 11; 30% of initial val-
ue), and fi nally to 478 U/L (at day 49; 5% of initial 
value). The highest increased in AST (339 U/L, 4.5-
fold), ALT (475 U/L, 10.3-fold) and LD (545 U/L, 1.5-
fold) were registered on the 3rd day, and the high-
est increase in GGT (68 U/L, 3.1-fold) occurred on 
the 11th day. Seven weeks after discharge AST, ALT, 
GGT and LD decreased into reference range, and 
ALP remained mildly increased (478 U/L, 1.1-fold 
increase). During acute illness De Ritis quotient re-
mained < 1, and at control testing it increased at 
normal value, i.e. 1.09. All the time concentrations 
of bilirubin remain decreased (bellow lower refer-
ence value for age, i.e. < 6 μmol/L). During hospi-
talization, erythrocyte sedimentation rate, ESR, re-
mained increased. Leukocyte count, as well as the 
concentration of C-reactive protein, was into refer-
ence range. In addition, initial values of IgG (9.3 
g/L) and IgA (0.47 g/L) were less than upper limit 
of the reference range for age, and IgM (1.48 g/L) 
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was moderately increased (upper limit = 1.43 g/L). 
RSV was confi rmed in nasal lavage fl uid.
Discussion
Transient increase in catalytic activities of ALP, AST, 
ALT, GGT and LD revealed that the acute hepatitis 
may appear during the RSV-infection. According 
to our knowledge this is the fi rst overview of mark-
edly (24-fold) increased ALP during RSV-infection 
in children.
Respiratory syncytial virus (RSV) is medium-sized 
enveloped RNA paramyxovirus (8). In community, 
it spreads by direct contact, and replicates in na-
sopharingeal epithelium. In the next few days it 
spreads to respiratory epithelial cells of lower res-
piratory system. The transit of RSV to distant or-
gans takes place haematogenously (9). The most 
studies on RSV-infections are related to pulmonary 
diseases. During RSV-infection, children up to two 
years of age have a high risk of concomitant acute 
AOM as a complication (10). In a systemic review, 
Eisenhut had point out to extrapulmonary mani-
festations of RSV-infections, especially in patients 
with severe clinical presentation (5). However, our 
patient was moderately ill, and extrapulmonary 
manifestations of viral infection were not expected.
The fact that RSV-infection has shown the biennial 
cycle (3) enables the prospective planning of meas-
ures to control infection. In 2009, the American
Association of Pediatrics (APP) has published a mod-
ifi ed recommendations for the prevention of RSV-
infection, using a humanized monoclonal antibody 
(directed against an epitope of RSV), Palivizumab 
(11). It is approved for the prevention of RSV disease 
in children up to 24 months, who are at high-risk 
because of prematurity and prematurity-associated 
lung diseases or congenital heart diseases.
Catalytic activites of enzymes and De Ritis quo-
tient in our patient were typical for acute hepatitis 
(12). So, the present case report presents at least 
two issues for discussion: 1) concomitant infection 
with hapatotrophic viruses, eg. Epstein-Barr virus-
infection, citomegalovirus (CMV)-infection, or in-
fl uenca-virus, and 2) drug-side-eff ect, respectively. 
Hepatitis is common characteristics of viral infec-
Analyte Day 1st Day 3rd Day 11th Day 49th Reference interval
Erythrocyte sedimentation rate (mm) 44 62 68 18 0–20
Leukocytes (N x 109/L) 12.1 9.8 8.9 7.5 6.0-16.0
C-reactive protein (mg/L) 0.7 0.5 – 0.5 0.1-2.8






























































ALP - alkaline phosphatase; AST - aspartate aminotranspherase; ALT - alanine aminotranspherase; GGT - gamma glutamyltranspherase; LD - 
lactate dehydrogenase; De Ritis quotient = AST/ALT ratio
TABLE 1. Results of laboratory analyses during hospital treatment (day 1, 3 and 11) and after home treatment (day 49).
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tions, eg. Epstein-Barr virus-infection (13), CMV (14), 
or infl uenca-virus (15). So, it may be presumed that 
a similar pathomechanism of “collateral damage” 
of the hepatocytes could cause RSV-associated 
hepatitis. As the child has been febrile four days 
before admission, and was treated with antipyret-
ics, transitory increase in catalytic activities of en-
zymes may be explained as side-eff ect of antipy-
retic medication. In children, acetaminophen (pa-
racetamol) is often used for antipyresis, and it may 
cause transitory acute liver impairment (16). Eisen-
hut et al. have shown aminotranspherases to be 
increased in children with RSV-infection (17). More-
over, elevation of aminotranspherases (with peak 
value between two and four days after admission) 
due to hepatitis in these children was in correla-
tion with the severity of respiratory disease (18), 
and increased ALT of nearly 3000 U/L was associ-
ated with severe hepatitis (5). The peak values of 
aminotranspherases and LD in the present study 
were registered at the 3rd day after admission to 
daily hospital. The half-life of ALP is referred to be 
between 5 and 25 days (12).
Benign transient hyperphosphatasemia (BTH) may 
appear during the season of viral infections (19-21). 
Our previous investigation revealed that both, 
bacterial and viral infections may be a direct cause 
of BTH (22). In that study, children with bacterial 
respiratory infection had higher ALP values than 
children with viral infections. However, in children 
with BTH there is no evidence of metabolic bone 
or liver disease. Increased catalytic activity of ALP 
is isolated and transient laboratory fi nding (23), 
and it returns into reference interval within four 
months (19). In patients with BTH, ALP may have 
10-fold increase. In our previous study, values of 
ALP were in the range 528-5622 U/L (22), and Dori 
et al. have shown ALP values to be in the range 
805-8619 U/L (24). Values of ALP over 10000 U/L 
are very rare in BTH – one case with 11900 U/L has 
been registered by Eyman et al. (25). Markedly in-
crease of ALP at the admission in the child with 
hepatitis in the present paper has shown signifi -
cant decrease at the 3rd day. It means that RSV-in-
fection may cause short-time increase of ALP at 
the very beginning of hepatitis.
As liver biopsy is too aggressive and not ethically 
justifi ed, determination of cytoxine and chemok-
ine may be useful in assessment of the severity of 
RSV infection. Cepika A-M et al. have shown that 
low expression of chemokine receptor CX3 CR1 
and perforin in peripheral blood had been linked 
to a more severe RSV-disease presentation in in-
fants (26). In addition, cytokine polymorphisms 
have been associated with severity of rhinovirus or 
RSV infection as well as the frequency of AOM as a 
complication (27).
Oxidative stress contributes to the pathogenesis 
of lung infl ammatory diseases (28). During infec-
tion-associated oxidative stress, human cells are 
exposed to high concentration of reactive oxygen 
species, ROS (29). In vitro and in vivo investigations 
have shown that RSV infection induces production 
of ROS (30). Moderately increased concentrations 
of serum bilirubin may improve outcome of dis-
ease. Since circulating bilirubin is considered to be 
an endogenous anti-oxidant (31), low serum bi-
lirubin in our patient may reveal that oxidant - anti-
oxidant balance has been impaired.
Signs and symptoms of respiratory manifestations 
and symptoms of AOM due to RSV infections dis-
appear in about two weeks. However, the recovery 
phase of hepatitis during RSV-infection may last 
for weeks. Therefore catalytic activities of liver en-
zymes should be monitored until they return into 
reference range.
The main limitation of this case study is that ALP 
isoenzymes have not been identifi ed. Therefore it 
is not clear whether markedly increased ALP is the 
consequence of the mechanism of transient hy-
perphosphatasemia or the mechanism of RSV-in-
duced hepatitis. Additional serious limitation to 
this work is lack of proof that the liver function im-
pairment was caused by RSV.
Laboratory results in patients with RSV infection 
needs to be interpreted in the light of both, respi-
ratory and extrapulmonary manifestations of the 
infection, respectively.
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